{"id":200592,"date":"2022-01-14T16:30:13","date_gmt":"2022-01-14T16:30:13","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=200592"},"modified":"2022-01-14T16:30:13","modified_gmt":"2022-01-14T16:30:13","slug":"100-cei-mai-admirati-ceo-din-romania-2021-dragos-damian-ceo-terapia-ranbaxy-038","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=200592","title":{"rendered":"100 Cei mai admira\u0163i CEO din Rom\u00e2nia 2021. Drago\u015f Damian, CEO Terapia Ranbaxy &#8211; 038"},"content":{"rendered":"<div>\n<p>\nDrago\u015f Damian a preluat pentru a doua oar\u0103 conducerea Terapia Ranbaxy, unul dintre cei mai mari produc\u0103tori de medicamente generice din Rom\u00e2nia, \u00een 2010; a revenit atunci \u00een cadrul companiei dup\u0103 doi ani \u00een care a ocupat pozi\u0163ia de director general al Zentiva, alt mare produc\u0103tor de generice.<\/p>\n<p>\nA absolvit Universitatea de Medicin\u0103 \u015fi Farmacie din Cluj-Napoca \u015fi \u015fi-a \u00eenceput cariera \u00een industria farmaceutic\u0103 \u00een 1993, \u00een cadrul companiei Roche, unde a promovat rapid p\u00e2n\u0103 la pozi\u0163ia de medical manager.<\/p>\n<p>\n\u00centre 1999 \u015fi 2004 a avansat din postura de country manager conduc\u00e2nd reprezentan\u0163a Menarini\/Berlin-Chemie, apoi a fost cooptat de Terapia, unde a ocupat pe r\u00e2nd pozi\u0163ia de director comercial, respectiv CEO, odat\u0103 cu preluarea companiei Terapia de c\u0103tre grupul Ranbaxy.<\/p>\n<\/div>\n<p>\nPe l\u00e2ng\u0103 producerea medicamentelor generice, compania pe care o conduce cuprinde \u015fi unit\u0103\u0163i de cercetare \u015fi dezvoltare, laboratoare de calitate, de farmacovigilen\u0163\u0103, de studii clinice \u015fi de bioechivalen\u0163\u0103. Aceasta a \u00eenregistrat o cifr\u0103 de afaceri de 791 milioane de lei \u015fi un profit net de 191,8 milioane de lei \u00een 2020, av\u00e2nd un num\u0103r mediu de 849 de salaria\u0163i, potrivit datelor publice disponibile.<\/p>\n<p>\n&nbsp;<\/p>\n<p>\n<strong><span style=\"background-color:#ffd700;\">Top 3 priorit\u0103\u0163i pentru viitor:<\/span><\/strong><\/p>\n<p>\n<strong><span style=\"background-color:#ffd700;\">1.<\/span><\/strong>\u008c Lansarea \u00een urm\u0103torii trei ani a 10 produse medicamentoase noi \u00een fiecare dintre \u0163\u0103rile pe care le am \u00een administrare, incluz\u00e2nd anticorpi monoclonali inovativi \u015fi biosimilare.<\/p>\n<p>\n<strong><span style=\"background-color:#ffd700;\">2.<\/span><\/strong>\u008d L\u0103rgirea ariei de acoperire din exporturi prin includerea a cinci noi pie\u0163e de destina\u0163ie \u00een Uniunea Euro-Asiatic\u0103.<\/p>\n<p>\n<strong><span style=\"background-color:#ffd700;\">3.<\/span><\/strong>\u008e Continuarea investi\u0163iilor industriale \u00een modernizare \u015fi extindere, de circa 5 milioane de euro \u00een fiecare an.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drago\u015f Damian a preluat pentru a doua oar\u0103 conducerea Terapia Ranbaxy, unul dintre cei mai mari produc\u0103tori de medicamente generice din Rom\u00e2nia, \u00een 2010; a revenit atunci \u00een cadrul companiei dup\u0103 doi ani \u00een care a ocupat pozi\u0163ia de director general al Zentiva, alt mare produc\u0103tor de generice. A absolvit Universitatea de Medicin\u0103 \u015fi Farmacie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510,3850],"tags":[50309,558,8500],"class_list":["post-200592","post","type-post","status-publish","format-standard","hentry","category-actualitate","category-lideri","tag-100-cei-mai-admirati-ceo-din-romania-2021","tag-dragos-damian","tag-terapia-ranbaxy"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/200592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=200592"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/200592\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=200592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=200592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=200592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}